Daley and colleagues recently showed that γδ T-cells outnumber CD8+ T-cells in human pancreatic adenocarcinoma tissues, and potentially dampen the anti-tumor activity of conventional TCR αβ T-cells (245). This evidence concerns the gene CD8A and neoplasm.